Preliminary data from a Phase 1b dose escalation study of OP-1250, an oral CERAN, in combination with palbociclib in patients with advanced and/or metastatic estrogen receptor (ER)-positive, HER2-negative breast cancer

被引:0
|
作者
Chan, Arlene
Day, Daphne
Hui, Rina
McCarthy, Nicole
Wilson, Rosalind
Faltaos, Demiana
Shaw, Morena
Murphy, Caitlin
机构
关键词
D O I
10.1158/1538-7445.SABCS22-P3-07-15
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3-07-15
引用
收藏
页数:3
相关论文
empty
未找到相关数据